A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Clinical trial NCT06238622 · RECRUITING

Trial details

NCT number: NCT06238622
Sponsor: Boehringer Ingelheim
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis Progressive Pulmonary Fibrosis

Start date: 2024-05-06
Primary completion: 2027-04-28
Enrollment: 1700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.